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Arthroscopic surgery for degenerative knee: systematic review 
and meta-analysis of benefits and harms
J B Thorlund,1 C B Juhl,1, 2 E M Roos,1 L S Lohmander1, 3, 4
ABSTRACT
ObjeCtive
To determine benefits and harms of arthroscopic knee 
surgery involving partial meniscectomy, debridement, 
or both for middle aged or older patients with knee 
pain and degenerative knee disease.
Design
Systematic review and meta-analysis.
Main OutCOMe Measures
Pain and physical function.
Data sOurCes
Systematic searches for benefits and harms were 
carried out in Medline, Embase, CINAHL, Web of 
Science, and the Cochrane Central Register of 
Controlled Trials (CENTRAL) up to August 2014. Only 
studies published in 2000 or later were included for 
harms.
eligibility Criteria fOr seleCting stuDies
Randomised controlled trials assessing benefit of 
arthroscopic surgery involving partial meniscectomy, 
debridement, or both for patients with or without 
radiographic signs of osteoarthritis were included. For 
harms, cohort studies, register based studies, and 
case series were also allowed.
results
The search identified nine trials assessing the benefits 
of knee arthroscopic surgery in middle aged and older 
patients with knee pain and degenerative knee 
disease. The main analysis, combining the primary 
endpoints of the individual trials from three to 24 
months postoperatively, showed a small difference in 
favour of interventions including arthroscopic surgery 
compared with control treatments for pain (effect size 
0.14, 95% confidence interval 0.03 to 0.26). This 
difference corresponds to a benefit of 2.4 (95% 
confidence interval 0.4 to 4.3) mm on a 0-100 mm 
visual analogue scale. When analysed over time of 
follow-up, interventions including arthroscopy showed 
a small benefit of 3-5 mm for pain at three and six 
months but not later up to 24 months. No significant 
benefit on physical function was found (effect size 
0.09, −0.05 to 0.24). Nine studies reporting on harms 
were identified. Harms included symptomatic deep 
venous thrombosis (4.13 (95% confidence interval 1.78 
to 9.60) events per 1000 procedures), pulmonary 
embolism, infection, and death.
COnClusiOns
The small inconsequential benefit seen from 
interventions that include arthroscopy for the 
degenerative knee is limited in time and absent at one 
to two years after surgery. Knee arthroscopy is 
associated with harms. Taken together, these findings 
do not support the practise of arthroscopic surgery for 
middle aged or older patients with knee pain with or 
without signs of osteoarthritis.
systeMatiC review registratiOn
PROSPERO CRD42014009145.
Introduction
Arthroscopic knee surgery with meniscus resection is 
common for middle aged or older people with persistent 
knee pain.1-3 The knees of these patients often show 
“degenerative” lesions of cartilage, meniscus, and other 
tissues, suggestive of osteoarthritis. However, popula-
tion based studies using magnetic resonance imaging 
show that incidental findings of such lesions are also 
very common among people without knee symptoms 
and among those without plain radiographic signs of 
osteoarthritis, suggesting that the clinical significance 
of such findings is unclear.4-6 All but one of the nine 
randomised clinical trials to date of arthroscopic sur-
gery in middle aged or older people with persistent 
knee pain failed to show an added benefit of interven-
tions including arthroscopic surgery over a variety of 
control treatments.7-15 Uncertainty thus exists about the 
benefit of arthroscopic surgery including meniscus 
resection for these patients. However, many specialists 
are convinced of the benefits of the procedure from 
their own experience,16-19 and several recent reports 
show an increase, or no decrease, in the incidence of 
arthroscopic knee surgery with meniscus resection 
during the past decade.3 20-23 The arthroscopic proce-
dures discussed here are reported to be associated with 
adverse events, including deep venous thrombosis, 
infections, cardiovascular events, pulmonary embo-
lism, and death.24-26
The balance of benefits and harms weighs impor-
tantly in the choice of treatment. To inform the choice 
of treatment for these patients, we did a comprehen-
sive, up to date systematic review and meta-analysis of 
the benefits and harms of arthroscopic surgery 
WhAT IS AlReAdy knoWn on ThIS TopIC
Arthroscopic knee surgery is frequently and increasingly used to treat middle aged 
and older patients with persistent knee pain
All but one published randomised trials have shown no added benefit for 
arthroscopic surgery over that of the control treatment, but many specialists are 
convinced of the benefits of the surgical intervention
WhAT ThIS STudy AddS
Interventions that include arthroscopy are associated with a small benefit and with 
harms; the small benefit is inconsequential and of short duration
The benefit is markedly smaller than that seen from exercise therapy as treatment 
for knee osteoarthritis
These findings do not support the practice of arthroscopic surgery as treatment for 
middle aged or older patients with knee pain with or without signs of osteoarthritis
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 compared with control treatments for middle aged and 
older people with persistent knee pain. We extend exist-
ing knowledge by including more patients and by pre-
senting outcomes on pain, function, and harms in 
patients ranging from those with degenerative meniscal 
tears and no radiographic signs of osteoarthritis to 
those with degenerative meniscal tears and more severe 
signs of osteoarthritis. We also accounted for the study 
designs used and, when appropriate, did a priori 
defined subgroup analyses.
Methods
We used the preferred reporting items for systematic 
reviews and meta-analyses (PRISMA) statement as a 
guideline for this study.27
eligibility criteria
We included randomised controlled trials assessing the 
benefits (pain and physical function) of arthroscopic 
surgery involving partial meniscectomy, debridement, 
or both for patients with or without osteoarthritis com-
pared with non-surgical treatments such as sham sur-
gery (including lavage), exercise, and medical 
treatment. Our aim was to include studies on middle 
aged and older patients, but we applied no restriction 
on age in the search as degenerative knee disease is rare 
before middle age. We excluded studies on patients 
with concomitant cruciate ligament injuries. For the 
search on harms, we also allowed cohort studies, regis-
ter based studies, and case series, again excluding stud-
ies on patients with concomitant cruciate ligament 
injuries.
literature search and study selection
We did systematic searches for benefits and harms in 
Medline, Embase, CINAHL, Web of Science, and the 
Cochrane Central Register of Controlled Trials (CEN-
TRAL) in April 2014 and updated them in August 2014. 
Owing to advances in surgical and anaesthetic proce-
dures over time, we included only studies published in 
2000 or later for harms. We adjusted the search strate-
gies according to the specifications of the individual 
database (see web appendix). We set no search restric-
tions for follow-up time, patients’ age, study size, or 
language. Two members of the study team inde-
pendently assessed all titles and abstracts of identified 
reports for eligibility (benefits: JBT and CBJ; harms: JBT 
and LSL). We obtained the full text if at least one of the 
reviewers judged a study to be eligible. We reviewed ref-
erence lists of included studies to identify additional 
studies. Disagreements on inclusion were resolved by 
consensus.
Data extraction
The pre-specified outcomes for benefits were patient 
reported pain and physical function. When a report pro-
vided data on more than one pain or physical function 
scale, we used a published hierarchy for selection of 
patient reported outcomes (please refer to the PROS-
PERO protocol).28  We extracted outcomes for all 
reported follow-up assessments in the included studies. 
For the primary analysis on pain and physical function, 
we used data from the primary follow-up time as 
defined in the individual studies, varying from three to 
24 months. If a study did not explicitly state a primary 
follow-up time, we included the longest follow-up time 
from the initial trial report in the primary analysis. We 
extracted the standard deviation or estimated it from 
the confidence interval, the P value, or the interquartile 
range or used other methods recommended by the 
Cochrane Handbook for Systematic Reviews.29 If neces-
sary, we approximated means and measures of disper-
sion from figures in the included studies.
In addition to the outcomes specified above, we 
extracted the number of participants allocated to inter-
vention and control groups, distribution of sex, mean 
age at baseline, body mass index at baseline, baseline 
pain (transformed into a visual analogue pain scale 
from 0 to 100 mm), and interventions performed in the 
intervention and control groups. We also extracted data 
on the presence or absence of radiographic knee osteo-
arthritis in the study populations. As some studies 
included patients both with and without radiographic 
knee osteoarthritis, we divided the studies into three 
subgroups on the basis of the population included: no 
radiographic knee osteoarthritis population (that is, all 
patients had Kellgren and Lawrence grade 0 or 130 ); 
radiographic knee osteoarthritis population (that is, all 
patients had Kellgren and Lawrence grade 2 or higher); 
and mixed population (some patients with and some 
without radiographic knee osteoarthritis). For studies 
using the Ahlbäck scale for defining radiographic knee 
osteoarthritis,31 we considered a grade of 0 as no radio-
graphic knee osteoarthritis and grade 1 or higher as 
radiographic knee osteoarthritis.
We extracted all adverse events reported. However, 
we had decided a priori to do meta-analysis only on the 
following adverse events: deep venous thrombosis, 
pulmonary thromboembolism, venous thromboembo-
lism, infection, and death (all cause mortality). We 
chose these adverse events on the basis of a prelimi-
nary search and their seriousness and frequency. If a 
study did not report the rate of venous thromboembo-
lism but reported both deep venous thrombosis and 
pulmonary thromboembolism, we combined the last 
two to generate a venous thromboembolism variable 
for meta-analysis.
In addition to adverse events, we registered the study 
design, mode of reporting (that is, per patient or per 
procedure), sample size, period of adverse events col-
lection, types of adverse events, and number of adverse 
events. We used customised forms to independently 
extract all data for benefits (JBT, CBJ) and harms (JBT, 
CBJ, LSL).
synthesis of results
For the analysis on benefits, we calculated the effect 
sizes in the individual studies as standardised mean 
differences, allowing pooling and comparison of the 
various outcomes assessed in the individual trials. We 
estimated the standardised mean difference as the 
 difference between the mean score of the intervention 
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and control groups divided by the pooled standard 
deviation of the final score. This estimate of the effect 
size using standardised mean difference has a slight 
bias overestimating the effect size, and we applied a 
correction factor to convert the effect size to Hedges’ g.32
We used meta-analysis to combine the individual 
study results by using the Stata software package (ver-
sion 13.0). We applied the REstricted Maximum Likeli-
hood (REML) method to estimate the combined effect 
size and the between study variance. We examined het-
erogeneity between trials with Q tests and calculated 
the I2 statistic,33  measuring the proportion of variation 
(that is, inconsistency) in the combined estimates due 
to between study heterogeneity.34  We transformed the 
effect size measured as standardised mean difference 
into a visual analogue scale ranging from 0 to 100 mm 
by multiplying it by a standard deviation equal to 16.9 
mm for pain and 16.6 mm for physical function.35  The 
standard deviations used for conversion of stan-
dardised mean difference to millimetres were based on 
a cohort of 914 patients with knee osteoarthritis.36  Fur-
thermore, we used the formula proposed by Chinn in 
the Cochrane Handbook to estimate the odds ratio and 
number needed to treat.35-38
We analysed the effect of arthroscopic surgery involv-
ing partial meniscectomy, debridement, or both for 
patient reported pain and physical function. We did 
subgroup analyses to explore the effect of severity of 
degenerative knee disease defined by presence of radio-
graphic knee osteoarthritis in the respective study pop-
ulations (no patients with radiographic knee 
osteoarthritis, patients with or without radiographic 
knee osteoarthritis, or all patients with radiographic 
knee osteoarthritis), the effect of partial meniscectomy 
with or without concomitant debridement, risk of bias, 
and type of study design. To investigate whether the 
results were dependent on follow-up time, we also did 
meta-analysis on all available follow-up time points 
with at least two studies available.
In the analysis on harms, we transformed the num-
bers of adverse events into log odds of events, allowing 
pooling of data from the individual studies. Results are 
reported as number of adverse events per 1000 proce-
dures with 95% confidence intervals. We applied a 
REML method to estimate the combined odds of events 
and the between study variance. We assessed study het-
erogeneity by calculating the I2 statistic.
risk of bias assessment
Two reviewers (JBT and CBJ) independently assessed 
risk of bias by using the Cochrane Handbook for Sys-
tematic Reviews of Interventions.29 For studies on ben-
efits, the two reviewers independently assessed 
sequence generation, allocation concealment, 
blinding, handling of incomplete outcome data, selec-
tive outcome reporting, and other bias. For harms, they 
assessed each of the included studies for description of 
intervention, type of adverse events reported, and loss 
to follow-up. Each of the domains was scored as “ade-
quate,” “inadequate,” or “unclear.” Disagreements 
were resolved by consensus. For a full elaboration on 
the criteria for each of the bias assessment domains, 
please refer to the study protocol (PROSPERO registra-
tion number CRD42014009145).
Patient involvement
There was no patient involvement in this study.
Results
benefits
The literature search yielded 1789 reports after exclu-
sion of duplicates. Of these, 18 were considered for 
inclusion after review of title and abstract. After full 
text review, six reports were excluded because of no or 
insufficient data on patient reported pain or physical 
function,39-44  and two were excluded because they 
were not clinical trial reports.45 46  We included 10 
reports on nine different trials in the systematic review 
(supplementary figure A).7 8-14 47  One report was not 
included in the final meta-analysis as it was a second-
ary trial report and the only one providing five year 
 follow-up data.47
Study characteristics
The nine included trials had randomly allocated 1270 
patients to interventions including arthroscopic sur-
gery with partial meniscectomy, debridement, or both 
or a variety of control treatments ranging from pla-
cebo surgery to exercise (supplementary table A). 
Mean age of patients in the individual trials ranged 
from 49.7 to 62.8 years. Mean baseline pain in the 
included studies ranged from 36 to 63 mm on a 0-100 
mm visual analogue scale. In two trials,8 10  all patients 
had radiographic knee osteoarthritis (Kellgren and 
Lawrence grade 2 or more); in five trials,7 9 11 12 15 47 
some of the patients had radiographic knee osteoar-
thritis; and in two trials,13 14 no patients had radio-
graphic knee osteoarthritis. The follow-up time for 
the primary endpoint in the trials varied between 
three and 24 months.
Synthesis of results
Our primary analysis for pain, combining the individual 
trials’ primary endpoints ranging from three to 24 
months, showed a small but statistically significant 
benefit for interventions including knee arthroscopy 
compared with control treatments (effect size 0.14, 95% 
confidence interval 0.03 to 0.26; I2=0.0%) (fig 1 and sup-
plementary table B). This effect size corresponds to a 
difference of 2.4 (95% confidence interval 0.4 to 4.3) mm 
between treatment groups on a 0-100 mm visual ana-
logue scale. Evaluation of between group differences at 
different postoperative time points showed a statisti-
cally significant benefit in favour of interventions 
including knee arthroscopy at three months (effect size 
0.27, 0.14 to 0.41; I2=20.6%) and six months (0.18, 0.05 to 
0.30; I2=0.0%) but not at later postoperative times (fig 2 
and supplementary table B). 
For physical function, we found no significant differ-
ence between interventions including knee arthroscopy 
and control treatments (effect size 0.09, −0.05 to 0.24; 
I2=11.9%) (fig 3 ). When evaluating physical function 
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over time, we found no between group differences at 
any of the analysed time points (fig 4).
Risk of bias
Agreement between assessors on risk of bias ranged from 
78% to 100% (that is, κ values ranging from 0.53 to 1.00). 
Only one included report was assessed as “adequate” on 
all domains (supplementary table C),14 and only two 
reports were assessed as “adequate” for blinding.8 14  The 
remaining studies were not blinded.7 9-13 15 47
Subgroup analysis
Analysis of the effect of risk of bias showed no differ-
ences between studies scored as adequate, unclear, or 
inadequate on any of the domains investigated (fig 5 
and supplementary figure B). We also did subgroup 
analyses on the primary endpoint analysis of pain 
and physical function for the osteoarthritis status of 
the study population (ranging from no radiographic 
osteoarthritis at all via a mixed population to all hav-
ing radiographic osteoarthritis) and for type of sur-
gery (partial meniscectomy with or without 
concomitant debridement) (fig 6  and supplementary 
figure C). These analyses did not change the interpre-
tation of the results from the primary analyses. Sub-
group analysis stratified for presence/absence of 
mechanical symptoms was not possible owing to lack 
of data. In a further subgroup analysis to evaluate the 
influence of study design, we found no differences 
between studies with different control interventions 
(fig 6 and supplementary figure C).
Harms
We screened titles and abstracts of 2330 reports after 
exclusion of duplicates; of these, 37 were reviewed as 
full text. This resulted in exclusion of 28 reports,48-75 
leaving nine reports for meta-analysis (supplementary 
figure A).12 14 24-26 76-79
Study characteristics
Two randomised trials and seven observational/registry 
studies reported on adverse events (supplementary 
table D).12 14 24-26 76-79 Quality of reporting of adverse 
events was frequently low in both observational studies 
and randomised clinical trials, and only two of nine 
arthroscopy trials provided useful information on 
adverse events.
Synthesis of results
Deep venous thrombosis was the most frequently 
reported symptomatic adverse event associated with 
arthroscopic meniscectomy, with 4.13 (95% confidence 
interval 1.78 to 9.60) events per 1000 procedures, fol-
lowed by infection, pulmonary embolism, and death 
(table 1  and supplementary table B). Heterogeneity of 
all the estimates was high (table 1).
Risk of bias
Only one study was assessed as “adequate” on all three 
domains (supplementary table E).12 All reports suffi-
ciently described the surgical intervention, but seven of 
nine studies reported only a few types of adverse events 
in the same report (supplementary table D).
discussion
In this meta-analysis, in which the primary endpoint of 
each of the nine included randomised trials ranged 
from three to 24 months after surgery, we found a small 
but statistically significant effect on pain relief from 
interventions including arthroscopic surgery compared 
with control treatments, corresponding to a 2.4 mm 
between group difference on a 0-100 mm visual 
 analogue scale. When we analysed pain for different 
 postoperative time points, the benefit favouring 
arthroscopic surgery was present only at three and six 
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fig 1 | results of primary analysis on benefit on patient reported pain of interventions 
including arthroscopic knee surgery compared with control interventions (follow-up time 
range: 3-24 months)
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fig 2 | effect of interventions including arthroscopic knee surgery compared with control 
interventions on patient reported pain presented as difference in mm on 0-100 mm visual 
analogue scale, with 95% confidence interval error bars. table below shows number of 
studies and patients included in analyses at different follow-up time points, with 
estimated difference between interventions calculated as effect size and estimates of 
heterogeneity (i2). Data from 2 months’ follow-up from Osteraas et al and sihvonen et al 
are included in 3 month estimate
RESEARCH
5the bmj | BMJ 2015;350:h2747 | doi: 10.1136/bmj.h2747
months, but not at later time points. We found no 
between group differences for self reported physical 
function in any of the analyses. Deep venous thrombo-
sis was the most frequently reported symptomatic 
adverse event, followed by infection, pulmonary embo-
lism, and death.
strengths and weaknesses
Previous systematic reviews have investigated the bene-
fits of knee arthroscopy in patients with established 
knee osteoarthritis or no/mild knee osteoarthritis.80  81 
To the best of our knowledge, ours is the first systematic 
review and meta-analysis to include both benefits and 
harms of arthroscopic surgery and to include the whole 
continuum of degenerative knee disease, ranging from 
patients with degenerative meniscal tears without radio-
graphic changes to those with meniscal tears and other 
joint changes combined with more severe radiographic 
changes. We included all identified randomised con-
trolled trials of arthroscopic surgery for the degenerative 
knee comparing interventions including arthroscopic 
surgery with control treatments. To facilitate interpreta-
tion of pain and function results, we based our analysis 
on patient reported pain and function. Composite mea-
sures of “knee function,” aggregating arbitrarily 
weighted more or less correlated items into one score, 
are notoriously difficult to interpret and were therefore 
not included. We also searched the literature for infor-
mation on harms associated with this intervention, and 
we included observational studies published from 2000 
onwards. The individual trials from different countries 
and populations showed consistent results, with low 
heterogeneity for benefit, whereas heterogeneity for 
harms was large.
Only two of the nine arthroscopy trials were adequate 
for blinding, and these trials included a control group 
with sham surgery. Many of the other trials, being inad-
equately blinded and using control groups with various 
non-invasive treatments, were assessed according to 
the Cochrane Collaboration criteria as having a high 
risk of bias.29  Given that invasive procedures have a 
stronger placebo effect than do non-invasive ones, the 
resulting bias from inadequate or absent blinding 
would be expected to favour the treatment arm includ-
ing arthroscopic surgery.82-85
The focus of five of the nine trials was, by study 
design, on the additional benefit from arthroscopic sur-
gery when the same non-surgical intervention was pro-
vided to both the intervention and comparator group. 
The exercise therapy component, applied both in the 
intervention and in the comparator arms, was in many 
cases of inadequate dose for an optimal efficacy or 
poorly described.86 In light of our incomplete under-
standing of the possible interaction between exercise 
therapy and a surgical intervention and their resulting 
combined efficacy, compared with the efficacy of exer-
cise therapy in isolation, the resulting direction of bias 
is uncertain.
The randomised controlled trials of arthroscopic sur-
gery were small, limiting their usefulness in assessing 
harms, and most of them provided no useful informa-
tion on adverse events. We therefore included observa-
tional studies to obtain information on harms 
associated with arthroscopic surgery involving menis-
cectomy, debridement, or both.87  The heterogeneity for 
assessing harms was high, reflecting differences in 
study size and design and quality of reporting of 
adverse events. Generally, the terminology and consis-
tency in reporting of adverse events was poor. We did 
not systematically search the literature for harms asso-
ciated with the control treatments, notably exercise. 
However, serious adverse events seem to be rare 
whereas minor events related to joint pain and muscle 
soreness are commonly reported from resistance train-
ing, including from patients with knee osteoarthritis.88
Meaning of study
The overall additional benefit on pain from arthroscopic 
surgery, using the primary endpoint of each trial, was 
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fig 3 | results of main analysis on benefit on patient reported physical function of 
interventions including arthroscopic knee surgery compared with control interventions 
(follow-up time range: 3-24 months)
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fig 4 | effect of interventions including arthroscopic knee surgery compared with control 
interventions on patient reported physical function presented as difference in mm on 
0-100 mm visual analogue scale, with 95% confidence interval error bars. table below 
shows number of studies and patients included in analyses at the different follow-up time 
points, with estimated difference between interventions calculated as effect size and 
estimates of heterogeneity (i2)
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small (effect size 0.14) and limited in time. This benefit is 
comparable to the small pain relieving effect on knee 
pain seen from paracetamol (effect size 0.14), less than 
that of non-steroidal anti-inflammatory drugs (0.29),89 
and markedly smaller than the moderate to large pain 
relieving effect seen from exercise therapy as treatment 
for knee osteoarthritis (overall standardised mean differ-
ence 0.50 regardless of type or dose, or 0.68 for exercise 
performed three times a week).86 A previous systematic 
review and meta-analysis of benefits of arthroscopy sug-
gested that a clinically relevant improvement for 
arthroscopic surgery in this patient group would corre-
spond to a standardised mean difference of 0.45.81  Effect 
sizes can be difficult to interpret, so we converted them to 
mm on a 0-100 visual analogue scale. The effect size of 
0.14 corresponds to difference of 2.4 mm. This is a negli-
gible difference on a 0-100 scale and much smaller than 
the 15-20 mm commonly suggested as representing a clin-
ically relevant difference for pain.90 Claims of benefit in 
subgroups of patients are not supported by published 
evidence.
We observed a substantial improvement in the inter-
vention group receiving surgery, corresponding to the 
clinical impression of many surgeons.16-19 Accordingly, 
recent reports show an increase, or no decrease, in the 
incidence of arthroscopic knee surgery in middle aged 
or older people with persistent knee pain.3 20-23 How-
ever, the improvements in the control groups were sim-
ilarly impressive, with no clinically relevant between 
group differences at any time point. This is in line with 
a recent systematic review of the use of placebo controls 
in the evaluation of surgery, with considerable improve-
ment in placebo arms of randomised trials and similar 
or only marginally superior benefit from surgery in half 
of the included studies.91  92
Arthroscopic meniscectomy is associated with 
short term risk of harms, of which the most common 
was deep venous thrombosis, and in rare cases 
death. Arthroscopic meniscus resection may also be 
associated with long term harms. Resection of the 
meniscus increases local contact pressures in the 
knee, increasing the risk for development of osteoar-
thritis.93-95 In support, patients with previous knee 
surgery undergo total knee arthroplasty at a signifi-
cantly younger age than do patients without previous 
knee surgery.96
Arthroscopic surgery in the middle aged and older 
population with knee pain represents most arthrosco-
pies and is routinely performed on the basis of a sus-
pected meniscal tear by clinical examination or as 
diagnosed by magnetic resonance imaging, the reason-
ing being that the pain is associated with the meniscal 
tear. However, meniscal tears and other structural 
abnormalities (such as osteophytes, cartilage damage, 
and bone marrow lesions) are characteristics of knee 
osteoarthritis, often coexist, and are common findings 
in painful knees but also commonly occur in pain-free 
knees in middle aged and older people.5 6  Such joint 
damage is often present without a history of distinct 
trauma but is considered to be of a “degenerative” 
nature and indicative of early knee osteoarthritis.5 
Thus, middle aged patients with knee pain and menis-
cal tears should be considered as having early stage 
osteoarthritis and be treated according to clinical 
guidelines for knee osteoarthritis, starting with infor-
mation, exercise, and often weight loss.97
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fig 5 | evaluation of risk of bias in primary analysis of pain. P value indicates difference 
between studies dependent on risk of bias scoring (that is, adequate, inadequate, and 
unclear)
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fig 6 | subgroup analysis on primary analysis of pain stratified by study population knee 
osteoarthritis status, surgery type, and study design. P value indicates difference between 
different subgroups
summary of meta-analysis on harms of arthroscopic meniscectomy
adverse event
no of studies (no of 
patients/procedures)
no of adverse events 
per 1000* (95% Ci) i2 (%)
Deep venous thrombosis 5 (432 663) 4.13 (1.78 to 9.60) 98.3
Pulmonary embolism 6 (736 823) 1.45 (0.59 to 3.54) 98.6
Venous thromboembolism 6 (571 793) 5.68 (2.96 to 10.9) 99.3
Infection 4 (946 230) 2.11 (0.80 to 5.56) 99.6
Death 2 (106 967) 0.96 (0.04 to 23.9) 90.3
*Mix of studies reporting per patient and per procedure.
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unanswered questions and future research
Available evidence supports the reversal of a common 
medical practice.98 However, disinvestment of com-
monly used procedures remains a challenge, and use of 
arthroscopy seems to be undiminished, in analogy with 
use of vertebroplasty following the publication of trials 
showing absence of benefit of this procedure.98 99 Sur-
geon confirmation bias in combination with financial 
aspects and administrative policies may be factors more 
powerful than evidence in driving practice pat-
terns.23 100-103
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